ABUS - Arbutus Biopharma GAAP EPS of -$0.10 beats by $0.03 revenue of $14.24M beats by $7.47M August, 04 2022 07:33 AM Arbutus Biopharma Corporation Arbutus Biopharma press release ( NASDAQ: ABUS ): Q2 GAAP EPS of -$0.10 beats by $0.03 . Revenue of $14.24M (+511.2% Y/Y) beats by $7.47M . For further details see: Arbutus Biopharma GAAP EPS of -$0.10 beats by $0.03, revenue of $14.24M beats by $7.47M